Posted On: 12/03/2015 2:41:10 PM
Post# of 72446
What was said was that the increase in dose was no longer getting the same increase in benefit I believe it was based on the first round at 750. It didn't say decreasing the benefit as some are trying to word it.
The company, scientist and doctors feel multiple dosing, basically keeping the Kevetrin in the system because of it's short life, will be more beneficial than higher dosing.
GLTM
The company, scientist and doctors feel multiple dosing, basically keeping the Kevetrin in the system because of it's short life, will be more beneficial than higher dosing.
GLTM
(0)
(0)
If you try to defend yourself against lies of the board moderators your post will be deleted. Just like the board they claim to be better than!!! Watch who you trust especially the "long term investors" that support the real attackers!
